CELU (celularity.com) Net Profit

CELU (celularity.com) - company brandmark

Celularity Inc. owns a US-based placental cell processing facility, controlling the entire biomaterial production cycle. The company is currently expanding sales in regenerative medicine and launching clinical trials to drive revenue growth. The implementation of ESG standards ensures bioethics and data protection. The company's profit volume reflects market dynamics, where the value of -0.05 serves as the baseline indicator for analyzing current trends.

CELU (Celularity Inc.) Net Profit history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company celularity.com (CELU)

- price and consensus price forecast:
Stock Quotes Celularity|CELU - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Celularity Inc.|CELU - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Celularity|CELU - Book Capitalization|Market Capitalization to Book Value celularity.com|CELU - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Celularity Inc.|CELU - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Celularity|CELU - Company Total Debt|Debts to Book Capitalization Celularity Inc.|CELU - Company Long-Term Debt|Company Short-Term Indebtedness Celularity|Immediate Liquidity celularity.com
- net income and valuation multiples indicators:
CELU - Net Profit
Summary company analysis:Celularity Inc.
Core merchandise of Celularity Inc

Celularity Inc. profits represent a cash flow generated by the business daily, stripped of accounting adjustments. By analyzing the net profit trend of Celularity Inc. on the GURU.Markets platform, an investor can observe the financial resilience of Celularity Inc. to geopolitical risks that could limit international cooperation in biotechnology, disrupt biomaterial logistics, or weaken global intellectual property protections.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Pharming Corp (PHAR) - Net Income|NKTR: Net Profit|Company Net Income upstreambio.com (UPB)|Company Net Income Zenas Biopharma|Company Net Income IMNM|Net Income GOSS (Gossamer Corp)|Net Profit KalVista Corp (KALV)|Company Net Income Septerna Inc SEPN|pieris.com - Company Net Income|Savara - Net Profit|RIGL - Net Profit|AnaptysBio Corp (ANAB) - Company Net Income|Astria Corp - Final Profit|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Net Income JBIO (Aerovate Therapeutics Inc)|Profit After Payment of Taxes ACRS|Kyverna - Net Income|Tiziana Life Sciences, Ltd. (TLSA) - Company Net Income|CABA: Net Income|Final Profit VTYX (ventyxbio.com)|THTX: Net Profit|AVTX - Net Financial Result|Company Net Income Eledon|Company Profit AGEN (Agenus, Inc)|Net Profit CLYM|Net Income zurabio.com ZURA|aTyr Pharma - Net Income|Net Financial Result Adagene Inc (ADAG)|Ikena Oncology, Inc. - Net Profit|Shattuck Labs, Inc. (STTK) - Net Income|EQ: Net Profit|Company Net Income Connect Biopharma Holdings Limited (CNTB)|Company Net Income Immunic Therapeutics|Company Net Income ATRA|Net Income IFRX (InflaRx N.V.)|Net Profit X4 Pharmaceuticals, Inc (XFOR)|Company Net Income Adicet Bio, Inc. ACET|INMB (inmunebio.com) - Profit After Tax|Barinthus Biotherapeutics plc - Net Profit|Final Profit KZR (Kezar Life Sciences Inc.)|SABS: Net Profit|Akari Therapeutics, Plc (AKTX) - Net Profit|Company Net Income Enlivex Therapeutics Ltd|QTTB: Final Profit|Company Net Income GeoVax (GOVX)|Net Income Edesa Biotech Inc EDSA|Net Profit IBIO (iBio Corp)|Net Profit Carisma Therapeutics Inc CARM|XTLB: Net Income|Final Profit BOLT (Bolt Biotherapeutics)|HCWB: Net Profit|APVO - Net Financial Result|Company Net Income AIM ImmunoTech|Net Income Aditxt Corp (ADTX)|Company Net Income GRI Bio, Inc. (GRI)|Net Income xortx.com XRTX|Vyome Holdings - Net Income|Net Profit Revelation Biosciences Inc REVB|INDP - Company Net Income|SCNI (BiondVax Pharmaceuticals) - Company Profit|CALI: Net Profit|Company Net Income Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Net Profit|Net Income HOOKIPA (HOOK)|Net Profit IGMS|ITOS - Company Net Income|Company Net Income Ocean Biomedical, Inc. OCEA|tcbiopharm.com - Company Net Income|THRD: Net Income